Image Description (1)
Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 83008-009
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 83008-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)
Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)
This text is a table showing Tramadol concentration levels in ng/mL over time for two different types of medication: Tramadol Hydrochloride Extended-Release Tablets (at 200 mg q.d) and Tramadol Hydrochloride Tablets (at 50 mg g6h). This information may be useful for medical professionals monitoring the effectiveness and safety of these medications.*
Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)
This is a chart that shows the concentration of M1 in ng/mL over time (in hours), comparing the effects of two medications. One medication is Tramadol Hydrochloride Extended-Release Tablets (200 mg taken once a day), the other is Tramadol Hydrochloride Tablets (50mg taken 6 times a day). The chart shows M1 concentration decreasing as time goes on.*
Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)
This appears to be a graph representing the percentage of patients achieving different levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis. The graph represents different doses of the tablets, with the 400mg dose having the highest percentage of patients achieving the response threshold. The x-axis represents the response threshold in percentage improvement from baseline, while the y-axis represents the percentage of patients achieving the response. Placebo is also represented in the graph.*
Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)
The text describes a study (Study 015) on the effectiveness of Tramadol Hydrochloride Extended-Release Tablets on Arthritis Pain Intensity in patients. The study measured patients achieving different levels of response threshold using a visual analog scale (VAS) responder analysis. The table shows the percentage of patients achieving response and placebo. The response threshold was measured in terms of percent improvement from baseline.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
